Search Results - "Fernandez, M E Elez"

585P - POLAF study: Efficacy and safety of FOLFIRI/aflibercept in a phase II trial in patients with metastatic colorectal cancer: Results of plasmatic prognostic and predictive markers by Fernandez, M E Elez, Gómez-España, M.A., Grávalos, C., García-Alfonso, P., Rodríguez, B., Losa, F., Ales-Diaz, I.C., Suarez, B Graña, Toledano, M., Valladares-Ayerbes, M., Marques, E Polo, Fernandez, M Salgado, de Castro, E Martínez, Raga, M Gil, Salvia, M A Salud, Ruiz-Casado, A., Rodríguez-Ariza, A., Aguilar, E Aranda

“…Biomarkers associated to antiangiogiogenic agents in metastatic colorectal cancer (mCRC) have not yet been validated Here we present the efficacy and safety…”
Get full text

585PPOLAF study: Efficacy and safety of FOLFIRI/aflibercept in a phase II trial in patients with metastatic colorectal cancer: Results of plasmatic prognostic and predictive markers by Fernandez, M E Elez, Gómez-España, M A, Grávalos, C, García-Alfonso, P, Rodríguez, B, Losa, F, Ales-Diaz, I C, Suarez, B Graña, Toledano, M, Valladares-Ayerbes, M, Marques, E Polo, Fernandez, M Salgado, de Castro, E Martínez, Raga, M Gil, Salvia, M A Salud, Ruiz-Casado, A, Rodríguez-Ariza, A, Aguilar, E Aranda

“…Abstract Background Biomarkers associated to antiangiogiogenic agents in metastatic colorectal cancer (mCRC) have not yet been validated Here we present the…”
Get full text

POLAF study: Efficacy and safety of FOLFIRI/aflibercept in a phase II trial in patients with metastatic colorectal cancer: Results of plasmatic prognostic and predictive markers by Fernandez, M E Elez, Gómez-España, M.A., Grávalos, C., García-Alfonso, P., Rodríguez, B., Losa, F., Ales-Diaz, I.C., Suarez, B Graña, Toledano, M., Valladares-Ayerbes, M., Marques, E Polo, Fernandez, M Salgado, de Castro, E Martínez, Raga, M Gil, Salvia, M A Salud, Ruiz-Casado, A., Rodríguez-Ariza, A., Aguilar, E Aranda

Get full text